Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 134

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 134
---
 shares.

Disclosure
of Share Ownership

In
general, under applicable securities regulation in Canada, a person or company who beneficially owns, or who directly or indirectly exercises
control or direction over voting securities of a reporting issuer, voting securities of an issuer or a combination of both, carrying
more than ten percent of the voting rights attached to all the issuer’s outstanding voting securities is an insider and must, within
ten days of becoming an insider, file a report in the required form effective the date on which the person became an insider, disclosing
any direct or indirect beneficial ownership of, or control or direction over, securities of the reporting issuer.

Additionally,
securities regulation in Canada provides for the filing of a report by an insider of a reporting issuer whose holdings change, which
report must be filed within five days from the day on which the change takes place.

Section
13 of the Exchange Act imposes reporting requirements on persons who acquire beneficial ownership (as such term is defined in the Rule
13d-3 under the Exchange Act) of more than five percent of a class of an equity security registered under Section 12 of the Exchange
Act. Our Common Shares are so registered. In general, such persons must file, within ten days after such acquisition, a report of beneficial
ownership with the SEC containing the information prescribed by the regulations under Section 13 of the Exchange Act. This information
is also required to be sent to the issuer of the securities and to each exchange where the securities are traded.

The
bylaws of the Company do not require disclosure of share ownership.

Meeting
of Shareholders

An
annual meeting of shareholders is held each year for the purpose of considering the financial statements and reports, electing directors,
appointing auditors and fixing or authorizing the Board to fix their remuneration and for the transaction of other business as may properly
come before a meeting of shareholders. Any annual meeting may also constitute a special meeting to take cognizance and dispose of any
matter of which a special meeting may take cognizance and dispose. Under the bylaws, our Chief Executive Officer or our President has
the power to call a meeting of shareholders.

  91  

The
CBCA provides that the holders of not less than 5% of our outstanding voting shares may requisition our directors to call a meeting of
shareholders for the purpose stated in the requisition. Except in limited circumstances, including where a meeting of shareholders has
already been called and a notice of meeting already given or